Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Borneo Journal of Pharmacy
Nurfina Dian Kartikawati
Universitas Muhammadiyah Magelang
Medicine & Pharmacology

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Interventions on Costs and Survival Rates of Lung Cancer Patients Fitriana Yuliastuti; Nurfina Dian Kartikawati; Missya Putri Kurnia Pradani; Cut Dewi Bunga; Roshan Kumar Mahato
Borneo Journal of Pharmacy Vol. 8 No. 4 (2025): Borneo Journal of Pharmacy
Publisher : Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33084/bjop.v8i4.10049

Abstract

Lung cancer is characterized by the uncontrolled growth of cells in the lung tissue, particularly in the lining of the respiratory tract. The disease has a high and alarming mortality rate, requiring prompt and appropriate management. This study aims to examine the costs and one-year survival rates of lung cancer patients at Dharmais Cancer Hospital. Data analysis was conducted in four stages: a retrospective observational study using secondary data from medical records, which described patient characteristics and factors affecting survival and treatment costs; analysis of survival curves by cancer stage and intervention; and testing differences in survival curves using the log-rank test. The results show that higher survival rates are often inversely proportional to shorter survival times, and vice versa. Stage 1 patients exhibited the most extended survival despite low survival rates for inpatients (48 months, 25%) and outpatients (53 months, 15%). Intervention types 4.00 (chemotherapy and radiotherapy) and 7.00 (chemotherapy, radiotherapy, and surgery) effectively extended survival, although associated survival rates remained low. The highest inpatient treatment costs were observed in stage 2 patients, while the highest annual outpatient costs were linked to surgical interventions, highlighting the difference between per-episode and cumulative annual expenditures.
Co-Authors Cut Dewi Bunga Fitriana Yuliastuti Missya Putri Kurnia Pradani Roshan Kumar Mahato